RT Journal Article
SR Electronic
T1 Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e001622
DO 10.1136/jitc-2020-001622
VO 8
IS 2
A1 Allouchery, Marion
A1 Lombard, Thomas
A1 Martin, Mickael
A1 Rouby, Franck
A1 Sassier, Marion
A1 Bertin, Celia
A1 Atzenhoffer, Marina
A1 Miremont-Salame, Ghada
A1 Perault-Pochat, Marie-Christine
A1 Puyade, Mathieu
YR 2020
UL http://jitc.bmj.com/content/8/2/e001622.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.